Comment on ‘Translating Prognostic Factors into Clinical Surveillance Decisions in Thin Melanoma’
Clicks: 10
ID: 322307
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
2.7
/100
10 views
2 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #35 of 176 articles by views in clinical and experimental dermatology
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 176 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
This correspondence emphasizes that identifying prognostic factors for recurrence in thin melanoma is only the first step, and that individualized surveillance should be guided by validated multivariable risk prediction models rather than isolated pathological features. It argues that calibration and decision curve analysis are needed to demonstrate whether risk-adapted follow-up provides meaningful clinical benefit beyond statistical significance. Finally, it highlights the need for external validation and contemporary data before these findings are incorporated into routine melanoma surveillance guidelines.
| Reference Key |
openalex_W7170459396
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Ercan Yılmaz, Nezihe Köker, Erdem Topal |
| Journal | clinical and experimental dermatology |
| Year | 2026 |
| DOI |
10.1093/ced/llag329
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.